Article
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.
Cancer immunology, immunotherapy : CII - 1 Sept 2021
Goldmann Torsten, Marwitz Sebastian, Nitschkowski Dörte, Krupar Rosemarie, Backman Max, Elfving Hedvig, Thurfjell Viktoria, Lindberg Amanda, Brunnström Hans, La Fleur Linnea, Mezheyeuski Artur, Mattsson Johanna Sofia Margareta, Botling Johan, Micke Patrick, Strell Carina
Abstract excerpt
Gene amplification is considered to be one responsible cause for upregulation of Programmed Death Ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC) and to represent a specific molecular subgroup possibly associated with immunotherapy response. Our aim was to analyze the frequency of PD-L1 amplification, its relation to PD-L1 mRNA and protein expression, and to characterize the immune microenvironment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
